Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Expert Opinion on Pharmacotherapy|February 9, 2026
Efficacy and safety of mirogabalin + opioids vs opioids alone for neuropathic cancer pain: Miro-CanpSaori Hashiguchi, Yoshihisa Matsumoto, Takaomi Kessoku, et al.Palliative Medicine Reports|December 20, 2021
Dexamethasone 8 mg for Cancer-Related Fatigue in Inpatients with Advanced Cancer Undergoing Palliative Care: A Multicenter Phase II TrialTomofumi Miura, Ayumi Okizaki, Hideaki Hasuo, et al.Pain Medicine (Malden, Mass.)|December 23, 2021
Prevalence of Myofascial Pain Syndrome and Efficacy of Trigger Point Injection in Patients with Incurable Cancer: A Multicenter, Prospective Observational Study (MyCar Study)Hiroto Ishiki, Hideaki Hasuo, Yoshinobu Matsuda, et al.BMJ Supportive & Palliative Care|April 1, 2024
Relationship between dyspnoea and related factors in patients with cancer: a cross-sectional studyYoshinobu Matsuda, Hideaki Hasuo, Keiichi Narita, et al.Biopsychosocial Medicine|March 9, 2023
Effects of eating together online on autonomic nervous system functions: a randomized, open-label, controlled preliminary study among healthy volunteersHideaki Hasuo, Nahoko Kusaka, Mutsuo Sano, et al.Japanese Journal of Clinical Oncology|March 7, 2022
Clinical practice guidelines for the care of psychologically distressed bereaved families who have lost members to physical illness including cancerTatsuo Akechi, Yosuke Kubota, Yoichi Ohtake, et al.Journal of Pain and Symptom Management|February 7, 2026
Factors indicating cancer-related neuropathic pain relief by corticosteroids administrationRintaro Koike, Keita Tagami, Takaomi Kessoku, et al.Japanese Journal of Clinical Oncology|March 28, 2020
JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statementsYoshinobu Matsuda, Hitoshi Tanimukai, Shinichiro Inoue, et al.BMJ Open|February 8, 2022
Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocolHiromichi Matsuoka, Katherine Clark, Belinda Fazekas, et al.Journal of Pain and Symptom Management|June 30, 2019
Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08)Hiromichi Matsuoka, Satoru Iwase, Tempei Miyaji, et al.Pageof 6